SANOFI-AVENTIS: A Chris le gusta la prensa...

Sanofi-Aventis CEO Chris Viehbacher has been all over the airwaves, parceling out one big piece of news after another.

First came the company's earnings and an interview with Forbes magazine. Then, Viehbacher told the Wall Street Journal Health Blog that it's likely he'll hook his animal health business back up with Merck's once the latter's Schering-Plough merger wraps. Over the weekend, the CEO told a German newspaper that he intends to double his vaccine business over the next five years. Finally, this morning the company announced an executive-suite reshuffle.

Ver...

Ver tambien...

Y además...